Protease inhibitors modulate apoptosis in mesangial cells derived from a mouse model of HIVAN

Kidney International

Volumn 65, Issue 3, 2004, Pages 860-870

  Mongia, Anil ^b   Bhaskaran, Madhu ^b   Reddy, Krishna ^b   Manjappa, Nagarathna ^b   Baqi, Noosha ^b   Singhal, Pravin C ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Apoptosis; HIV associated nephropathy; Mesangial cells; Protease inhibitors

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; CATALASE; DIPHENYLIODONIUM SALT; HEMIN; INDINAVIR; MORPHINE; PROTEINASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SAQUINAVIR; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; HIV ASSOCIATED NEPHROPATHY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY INFECTION; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE; VIRUS GENE;

EID: 1342280327     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00464.x     Document Type: Article

References (51)

1. WINSTON J, BURNS G, KLOTMAN P: HIV-associated nephropathy and the AIDS epidemic. Semin Nephrol 18:373-78, 1978
2. BOURGOIGNIE JJ: Renal complications of HIV-type infection. Kidney Int 37:1571-84, 1990
3. RAO TKS: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 40(Suppl 35):S13-S18, 1991
4. SINGHAL PC, GIBBONS N, ABRAMOVICI M: Long term effects of morphine on mesangial cell proliferation and matrix synthesis. Kidney Int 41:1560-1566, 1992
5. PARDO V, ALDANA M, COLTON RM, et al: Glomerular lesions in the acquired immunodeficiency syndrome. Ann Intern Med 101:429-434, 1984
6. HARRISON DJ: Cell death in the diseased glomerulus. Histopathol 12:679-683, 1988
7. SHIMIZU A, KITAMURA H, MASUDA Y, et al: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
8. BAKER AJ, MOONEY A, HUGHES J, et al: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
9. OKUDA S, LANGUINO LR, RUOSLAHTI E, et al: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
10. YAMAMOTO T, NOBLE NA, MILLER DE, et al: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
11. SUGIYAMA H, KASHIHARA N, MAKINO H, et al: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
12. HATTORI T, SHINDO S, KAWAMURA H: Apoptosis and expression of Bax protein and Fas antigen in glomeruli of a remnant-kidney model. Nephron 79:186-191, 1998
13. ZHANG W, KHANNA P, CHAN LL, et al: Diabetes-induced apoptosis in rat kidney. Biochem Mol Med 61:58-62, 1997
14. KIRCHNER JT: Resolution of renal failure after initiation of HAART: Three cases and a discussion of the literature. AIDS Reader 12:103-105, 110-112, 2002
15. SZCZECH LA, EDWARDS LJ, SANDERS LL, et al: Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol 57:336-341, 2002
16. COLLIER AC, COOMBS RW, SCHOENFELD DA, et al: Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med 334:1011-1017, 1996
17. SOUSA AE, CHAVES AF, DOROANA M, et al: Kinetics of the changes of lymphocytes subset defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection. J Immunol 162:3718-3726, 1999
18. PHENIX BN, ANGEL JB, MANDY F, et al: Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res Hum Retroviruses 16:559-567, 2000
19. LEVITZ SM: Improvement in CD4+ cell counts despite persistently detectable HIV load [letter]. N Engl J Med 338:1074-1075, 1998
20. WEICHOLD FF, BRYANT JL, PATI S, et al: HIV-1 protease inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells. J Hum Virol 2:261-269, 1999
21. SINGHAL PC, SHARMA P, LOONA R, et al: Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice. J Invest Med 46:297-302, 1998
22. PACE GW, LEAF CD: The role of oxidative stress in HIV disease. Free Radic Biol Med 19:523-528, 1995
23. MALORNI W, RIVABENE R, LUCIA BM, et al: The role of oxidative imbalance in progression to AIDS: Effect of the thiol supplier N-acetylcysteine. AIDS Res Hum Retroviruses 14:1589-1596, 1998
24. BECK MA, LEVANDER OA: Dietary oxidative stress and the potentiation of viral infection. Annu Rev Nutr 18:93-116, 1998
25. ROMERO-ALVIRA D, ROCHE E: The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med Hypotheses 51:169-173, 1998
26. GOUGEON ML, MONTAGNIER LL: Apoptosis in AIDS. Science 260:1269-1270, 1993
27. DOBMEYER T, FINDHAMMER S, DOBMEYER JM, et al: Ex vivo induction of apoptosis in lymphocyte is mediated by oxidative sress: Role for lymphocyte loss in HIV infection. Free Radic Biol Med 22:775-785, 1997
28. HALLIWELL B, GUTTERIDGE JMC: Reactive oxygen species in living systems: Source, biochemistry and role in human disease. Am J Med 91:14-22, 1991
29. SINGHAL PC, PAMARTHI M, SHAH R, et al: Morphine stimulates superoxide formation by glomerular mesangial cells. Inflammation 18:293-299, 1994
30. LI X, CLARK JD: Chronic exposure and the expression of heme oxygenase type 2. Mol Brain Res 75:179-184, 2000
31. SINGHAL PC, BHASKARAN M, PATEL J, et al: Role of P38 mitogen-activated protein kinase phosphorylation and Fas-FasL interaction in morphine-induced macrophage apoptosis. J Immunol 168:4025-4033, 2002
32. HERRMANN H, LORENZ HM, VOLL R, et al: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22:5506-5507, 1994
33. SLOAND EM, KUMAR PN, KIM S, et al: Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94:1021-1027, 1999
34. SLOAND EM, MACIEJEWSKI J, KUMAR P, et al: Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34+ cells. Blood 96:2735-2739, 2000
35. JOHNSON N, PARKIN JM: Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 113:229-234, 1998
36. WAN W, DE PETRILLO PB: Ritonavir protects hippocampal neurons against oxidative stress-induced apoptosis. Neuro Toxicol 23:301-306, 2002
37. MAINES MD: Heme oxygenase: function, multiplicity, regulatory mechanisms and clinical implications. FASEB J 2:2557-2568, 1988
38. NATH KA: Heme oxygenase-1: A redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 104:1485-1486, 1999
39. AGARWAL A, NICK HS: Renal response to tissue injury: Lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 11:965-973, 2000
40. WILLIS D, MOORE AR, FREDERICK R, et al: Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 2:87-90, 1996
41. LODHA S, DANI D, MEHTA R. et al: Angiotensin II-induced mesangial cell apoptosis; Role of oxidative stress. Mol Med 8:830-840, 2002
42. ZAGER RA, BURKHART KM, CONRAD DS, et al: Iron, heme oxygenase, and glutathione: Effects on myohemoglobinuric proximal tubular injury. Kidney Int 48:1624-1634, 1995
43. DONG Z, LAVROVSKY Y, VENKATACHALAM MA, et al: Heme oxygenase-1 in tissue pathology: The Yin and Yang. Am J Pathol 156:1485-1488, 2000
44. SUTTNER DM, DENNERY PA: Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J 13:1800-1809, 1999
45. GRIENDLING KK, MINIERI CA, OLLERENSHAW D, et al: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
46. MOLLANAU H, WENDT M, SZOCS K, et al: Effects of angiotensin infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58-E65, 2002
47. PESCE CM, STRIKER U, PETER E, et al: Glomerulosclerosis at both early and late stage is associated with cell turnover in mice transgenic for growth hormone. Lab Invest 65:601-605, 1991
48. FLOEGE J, BURNS MW, ALPERS CF, et al: Glomerular cell proliferation and matrix synthesis. Kidney Int 41:297-309, 1992
49. MICHAEL AF, KEANE WF, RAIJ L, et al: The glomerular mesangium. Kidney Int 17:141-154, 1980
50. FOGO AB: Progression and potential regression of glomerulosclerosis. Kidney Int 59:804-819, 2001
51. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988